PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
36.66
-0.36 (-0.97%)
At close: Sep 26, 2025, 4:00 PM EDT
36.67
+0.01 (0.03%)
After-hours: Sep 26, 2025, 7:33 PM EDT
PROCEPT BioRobotics Employees
PROCEPT BioRobotics had 756 employees as of December 31, 2024. The number of employees increased by 130 or 20.77% compared to the previous year.
Employees
756
Change (1Y)
130
Growth (1Y)
20.77%
Revenue / Employee
$363,690
Profits / Employee
-$111,304
Market Cap
2.04B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 756 | 130 | 20.77% |
| Dec 31, 2023 | 626 | 198 | 46.26% |
| Dec 31, 2022 | 428 | 194 | 82.91% |
| Dec 31, 2021 | 234 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PRCT News
- 6 weeks ago - Procept BioRobotics: Increasing Average Selling Price, Initiate At Buy - Seeking Alpha
- 7 weeks ago - PROCEPT BioRobotics Corporation (PRCT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance - GlobeNewsWire
- 2 months ago - PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO - GlobeNewsWire
- 2 months ago - Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy - GlobeNewsWire
- 2 months ago - PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025 - GlobeNewsWire
- 2 months ago - Aquablation® Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule - GlobeNewsWire
- 4 months ago - 19 stocks at the intersection of AI and robotics that could see big sales boosts - Market Watch